Topic
Who makes these drugs?
Novo Nordisk and Eli Lilly: the companies behind the drugs.
Eli Lilly's Pipeline: What Comes After ZepboundRetatrutide, eloralintide, bimagrumab and a $25 billion buying spree. What Eli Lilly is working on next, how far along each of it is, and why you should not try to buy any of it online.How Eli Lilly Became the World's Most Valuable DrugmakerA 150-year-old Indianapolis company went from a $93 billion valuation in 2017 to the first $1 trillion drugmaker in history. Here is the money, the decisions behind it, and the risk sitting underneath.How Ozempic Changed DenmarkOne drug from one company reshaped the economy of a country of six million people — and when the boom cooled in 2025, Denmark felt that too.Lilly vs. Novo Nordisk: The Obesity Drug War From Lilly's SideEli Lilly arrived five years late and took the lead anyway. Here is how the Indianapolis company played it, where it is losing, what it agreed with the Trump administration, and why both companies are now suing each other over advertising.Novo Nordisk's 2025 Crisis, ExplainedHow the maker of Ozempic and Wegovy went from Europe's most valuable company to a turnaround project in eighteen months — the guidance cuts, the ousted CEO, the 9,000 layoffs, and what has changed since.Novo Nordisk's Pipeline: What Comes After WegovyA plain-English guide to what Novo Nordisk is working on next — CagriSema, zenagamtide, cagrilintide, the oral pills already on the market, and the trials that failed along the way.Who Makes Mounjaro and Zepbound? Eli Lilly, ExplainedEli Lilly and Company makes both drugs, and they contain the same medicine. Here is who the company is, where the drugs are made, how LillyDirect works, and why the same molecule carries two different brand names.Who Makes Ozempic? Novo Nordisk ExplainedOzempic, Wegovy and the Ozempic pill are all made by Novo Nordisk, a 100-year-old Danish company controlled by a charitable foundation — here is how it works, where the drugs are made, and how much money it brings in.